Classifica tra le azioni
#32670
NuCana plc is a clinical-stage biopharmaceutical firm dedicated to pioneering... NuCana plc is a clinical-stage biopharmaceutical firm dedicated to pioneering advanced therapies for oncology. Its innovative product pipeline is underpinned by a proprietary ProTide technology platform. Among its key drug candidates, Acelarin is progressing through multiple clinical evaluations: a Phase I study for advanced solid tumors, Phase Ib trials for both recurrent ovarian cancer and biliary tract cancer, a Phase II trial targeting platinum-resistant ovarian cancer, and a pivotal Phase III trial for pancreatic cancer. NuCana is also developing NUC-3373, a ProTide derivative of 5-fluorouracil’s active anti-cancer metabolite. This compound is currently in a Phase I study for advanced solid tumors and a Phase Ib/2 trial for advanced colorectal cancer. Additionally, NUC-7738, a nucleoside analog, is undergoing Phase 1/2 clinical assessment for both advanced solid and hematological malignancies. To support its ProTide technology development, the company maintains research, collaboration, and licensing agreements with Cardiff University and University College Cardiff Consultants Ltd., covering the design, synthesis, characterization, and assessment of these compounds. Further collaborative and licensing arrangements are in place with Cardiff ProTides Ltd. Established in 1997, the company operated as NuCana BioMed Limited before rebranding to NuCana plc in August 2017. Its corporate headquarters are located in Edinburgh, United Kingdom.
Prezzo delle azioni
$1.51
Capitalizzazione di mercato
$9.14M
Variazione (1 giorno)
-5.35%
Variazione (1 anno)
-59.65%
Scambia NuCana plc (NCNA)
Il prezzo NCNA con la capitalizzazione del mercato della B
Capitalizzazione di mercato di NuCana plc(NCNA)
Capitalizzazione di mercato: $9.14M
A partire dal August 2026, NuCana plc ha una capitalizzazione di mercato pari a $9.14M. Questo rende NuCana plc la 32670th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di NuCana plc dal 2017 al 2026
NCNA in paragone con la classifica dei più popolari stocks
| Il prezzo per NCNA |
|
Attivo B |
Capitalizzazione del mercato a B |
Risultati |
|
|
|
|
$5.460T
|
+59,748,791.64%
|
|
|
|
|
$4.497T
|
+49,214,573.25%
|
|
|
|
|
$4.145T
|
+45,359,077.27%
|
|
|
|
|
$3.569T
|
+39,049,437.93%
|
|
|
|
|
$2.798T
|
+30,618,007.38%
|
